E-GEOD-45328 - Inactivation of TP53 correlates with disease progression and low miR-34a expression in previously treated chronic lymphocytic leukemia patients
Released on 21 March 2013, last updated on 3 June 2014
Micro-RNA expression data of CD19 selected B-cells from previously treated and relapsed chronic lymphocytic leukemia patients. We aimed to correlate miR-34a with TP53 mutation status and del17p status. CD19 B-cells from previously treated and relapsed chronic lymphocytic leukemia patients were selected for RNA extraction and hybridization on Affymetrix microarrays.
transcription profiling by array
Giuseppe Palermo <email@example.com>, Anna Dmoszynska, Annika Dufour, Christian H Geisler, David Dornan, Debraj GuhaThakurta, Evelyn Zellmeier, Galina Salogub, Gudrun Mellert, Guillemette Duchateau-Nguyen, Jan Braess, John Catalano, Karsten Spiekermann, Lin Wu, Marco Montillo, Martin Weisser, Nancy Patten, Philippe Solal-Celigny, Purvi M Kakadia, Ru-Fang Yeh, Sabine Lohmann, Sim Truong, Stephan K Bohlander, Stephanie Schneider, Tadeusz Robak, Tobias Benthaus, Wolfgang Hiddemann